141 related articles for article (PubMed ID: 10475142)
1. Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.
Vree TB; Waitzinger J; Hammermaier A; Radhofer-Welte S
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):393-403. PubMed ID: 10475142
[TBL] [Abstract][Full Text] [Related]
2. The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects.
Möller A; Iwasaki K; Kawamura A; Teramura Y; Shiraga T; Hata T; Schäfer A; Undre NA
Drug Metab Dispos; 1999 Jun; 27(6):633-6. PubMed ID: 10348790
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of acetylcholinesterase by distigmine bromide (Ubretid).
Breuel HP; Bohn-Olszewsky W; Engelsen SJ; Samhaber EM; Niklaus H
Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):230-5. PubMed ID: 8100221
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
[TBL] [Abstract][Full Text] [Related]
5. Disposition of oral [14C]cefcanel daloxate hydrochloride in healthy male subjects.
Edwall B; Arvidsson A; Lake-Bakaar D; Lanbeck-Vallén K; Yisak W
Drug Metab Dispos; 1993; 21(1):171-7. PubMed ID: 8095213
[TBL] [Abstract][Full Text] [Related]
6. Absolute bioavailability of amezinium. A cross-over study after i.v. and p.o. application.
Kaumeier S; Kehrhahn OH; Morgenthaler H; Neugebauer G
Arzneimittelforschung; 1981; 31(9a):1653-7. PubMed ID: 7197980
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
[TBL] [Abstract][Full Text] [Related]
8. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
[TBL] [Abstract][Full Text] [Related]
9. Oral forms of the oxime HI-6: a study of pharmacokinetics and tolerance after administration to healthy volunteers.
Jovanovic D; Maksimovic M; Joksovic D; Kovacevic V
Vet Hum Toxicol; 1990 Oct; 32(5):419-21. PubMed ID: 2238436
[TBL] [Abstract][Full Text] [Related]
10. [Intestinal absorption, organ and tissue distribution of 3H labelled distigmine bromide (true cholinesterase inhibitor) in rats and mice].
Kikuchi H; Sato A; Tomita S; Kano M
Nihon Naika Gakkai Zasshi; 1971 Apr; 60(4):299-304. PubMed ID: 5103723
[No Abstract] [Full Text] [Related]
11. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
Arzneimittelforschung; 1984; 34(1):92-5. PubMed ID: 6538428
[TBL] [Abstract][Full Text] [Related]
12. A crossover study after oral and intravenous administration of theophylline in male volunteers (absolute bioavailability of Afonilum tablets).
Kaumeier HS; Kehrhahn OH; Neugebauer G; Schuppan D; Schwarz JA; Staib AH
Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):339-45. PubMed ID: 6885204
[TBL] [Abstract][Full Text] [Related]
13. [Cholinergic crisis following administration of distigmine bromide: a case report].
Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
[TBL] [Abstract][Full Text] [Related]
14. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of huperzine A in dogs following single intravenous and oral administrations.
Chu D; Liu W; Li Y; Li P; Gu J; Liu K
Planta Med; 2006 May; 72(6):552-5. PubMed ID: 16773540
[TBL] [Abstract][Full Text] [Related]
16. [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment].
Kobayashi K; Sekiguchi H; Sato N; Hirose Y
Chudoku Kenkyu; 2016 Mar; 29(1):26-9. PubMed ID: 27255021
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
18. [Three cases of cholinergic crisis in which serum distigmine bromide concentrations were measured].
Onodera M; Fujino Y; Inoue Y; Endo S; Fujita Y
Chudoku Kenkyu; 2008 Jan; 21(1):75-81. PubMed ID: 18277557
[TBL] [Abstract][Full Text] [Related]
19. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
